발행물

전체 논문

207

41

Dietary schizophyllan reduces mitochondrial damage by activating          SIRT3 in mice.
Lee D, Kim YR, Kim JS, Kim D, Kim S, Kim SY, Jang K, Lee JD, Yang CS*
Arch Pharm Res., 2020.04

42

Rifamycin O, an alternative anti-Mycobacterium abscessus        agent.
Hanh BTB, Park JW, Kim TH, Kim JS, Yang CS, Jang K, Cui J, Oh DC, Jang J
Molecules, 2020

43

Sustainable Nanosheet Antioxidants for Sepsis        Therapy via Scavenging Intracellular Reactive Oxygen and Nitrogen Species.
Yim DB, Lee DE, So Y, Choi C, Son W, Jang K, Yang CS*, Kim JH*
ACS Nano, 2020.08

44

Host-directed therapy in tuberculosis: targeting host metabolism.
Kim JS, Kim YR, Yang CS*
Front. Immunol, 2020.08

45

A novel totivirus alters gene expression and vacuolar morphology in Malassezia cells and induces a TLR3-mediated inflammatory immune response.
Park M, Cho YJ, Kim D, Yang CS, Lee SM, Dawson T, Nakamizo S, Kabashima K, Lee YW, Jung WH
mBio, 2020.09

46

Etamycin as a Novel Mycobacterium abscessus Inhibitor.
Hanh BTB, Kim TH, Park JW, Lee DG, Kim JS, Du YE, Yang CS, Oh DC, Jang J
Int J Mol Sci., 2020.09

47

Toxoplasma gondii GRA9 Regulates the Activation of NLRP3      Inflammasome to Exert Anti-Septic Effects in Mice.
Kim JS, Mun SJ, Cho E, Kim D, Son W, Jeon HI, Kim HK, Jang K, Yang CS*
Int J Mol Sci., 2020.11

48

Mycobacteria Rv2626c-derived peptide as a therapeutic agent for            sepsis.
Kim SY, Kim D, Kim S, Lee D, Mun SJ, Cho E, Son W, Jang K, Yang CS*
EMBO Mol Med, 2020.12

49

Latest Comprehensive Knowledge of the Crosstalk between TLR Signaling and Mycobacteria and the Antigens      Driving the Process.
Kim JS, Kim YR, Yang CS*
J Microbiol Biotechnol., 2019.10

50

Toxoplasma gondii GRA8-derived peptide immunotherapy improves tumor targeting        of colorectal cancer.
Kim JS, Lee D, Kim D, Mun SJ, Cho E, Son W, Yang CS*
Oncotarget., 2020.01